Based on investigation of incorrect results related to the College of American Pathologists (CAP) surveys MRS5-A 2014 and MRS5-B 2014 using the BD-Max MRSA Assay it was confirmed that one of the samples for each of the surveys yielded some false positive results. While there is the potential for false positive result for specimens from patients who are positive for certain strains of Methicillin-Sensitive Staphylococcus aureus (MSSA) when present at high loads, BD believes that such an occurence is unlikely and overall clinical performance would not be affected.